Author:
Raghavan D.,Tannock I. F.
Reference127 articles.
1. Aabo K (1987) Prostate cancer: evaluation of response to treatment, response criteria, and the need for standardisation of the reporting of results. Eur J Cancer Clin Oncol 23: 231–236
2. Ackland SP, Vogelzang NJ (1988) New drugs and old toxicities. In: Raghavan D (ed) The management of bladder cancer. Edward Arnold, London, pp 189–227
3. Alfthan O, Andersson L, Esposti PH, et al. (1983) Cisobitan in treatment of prostatic cancer. A prospective controlled multicentre study. Scand J Urol Nephrol 17: 37–43
4. Anderson JR, Cain KC, Gelber RD (1983) Analysis of survival by tumor response. J Clin Oncol 1: 710–719
5. Andersson L, Berlin T, Boman J et al. (1980) Estramustine versus conventional estrogenic hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study. Scand J Urol Nephrol [Suppl] 55: 143–145
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献